OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,108,000 | -39.5% | 275,506 | -25.5% | 1.50% | -34.2% |
| Q1 2022 | $1,830,000 | -38.7% | 369,628 | -13.6% | 2.28% | +3.1% |
| Q4 2021 | $2,983,000 | -64.0% | 427,927 | -46.0% | 2.21% | -40.2% |
| Q3 2021 | $8,275,000 | -6.5% | 792,775 | +27.0% | 3.70% | +3.2% |
| Q2 2021 | $8,851,000 | +23.6% | 624,201 | +43.1% | 3.58% | +26.8% |
| Q1 2021 | $7,160,000 | +397.6% | 436,307 | +527.8% | 2.82% | +275.7% |
| Q4 2020 | $1,439,000 | +102.1% | 69,501 | -25.7% | 0.75% | +68.6% |
| Q3 2020 | $712,000 | +115.8% | 93,587 | +24.8% | 0.45% | +38.1% |
| Q2 2019 | $330,000 | – | 75,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |